Evolution of the Average Target: Brown-Forman Corporation

Evolution of the Target Price: Brown-Forman Corporation

Changes in Analyst Recommendations: Brown-Forman Corporation

0175dd8d1708f413c6674cde1e31.m2FP4CRjgmapLUvhODQfoGExKmWEY_k2guzoiZNOt8E.1i03kBcr8leceimjDFcqzlEcRyPmAJFCs66588kjzpeqJw3ZXVXEDdxrOA~57d94d9c3891a351f844fe1ed3cd2296
16/01 BNP Paribas Exane Downgrades Brown-Forman to Underperform From Neutral, Adjusts PT to $24 From $31 MT
14/01 Citigroup Adjusts Price Target on Brown-Forman to $24 From $27, Maintains Sell Rating MT
18/12 Brown-Forman Shares Fall After Citigroup Downgrade MT
17/12 Citigroup Downgrades Brown-Forman to Sell From Neutral, Adjusts Price Target to $27 From $30 MT
05/12 Brown-Forman's Blackberry Beats Expectations, But Soft Underlying Trends Persist, RBC Says MT
05/12 Deutsche Bank Adjusts Price Target on Brown-Forman to $30 From $29, Maintains Hold Rating MT
05/12 JPMorgan Adjusts Price Target on Brown-Forman to $28 From $29, Maintains Underweight Rating MT
05/12 Evercore ISI Adjusts Price Target on Brown-Forman to $32 From $30, Maintains In Line Rating MT
02/12 Brown-Forman Topline Visibility Likely Cloudy, RBC Says MT
26/11 Barclays Adjusts Price Target on Brown-Forman to $31 From $30, Maintains Overweight Rating MT
06/25/06 Barclays Adjusts Price Target on Brown-Forman to $30 From $32, Maintains Overweight Rating MT
15/25/15 Bernstein Adjusts Brown-Forman Price Target to $37.50 From $40, Maintains Outperform Rating MT
02/25/02 JPMorgan Adjusts Price Target on Brown-Forman to $29 From $30, Maintains Underweight Rating MT
29/25/29 UBS Trims Price Target on Brown-Forman to $32 From $33, Maintains Neutral Rating MT
29/25/29 Brown-Forman Needs to Post Multiple Quarters of Consistency to Regain Investor Confidence, RBC Says MT
29/25/29 Barclays Adjusts Price Target on Brown-Forman to $32 From $33 MT
29/25/29 Citigroup Adjusts Price Target on Brown-Forman to $30 From $31, Maintains Neutral Rating MT
26/25/26 Brown-Forman Faces Topline Pressure in Fiscal Q1 Amid Soft US Spirits Market Trends, RBC Capital Says MT
26/25/26 BNP Paribas Exane Adjusts Price Target on Brown-Forman to $31 From $29, Maintains Neutral Rating MT
22/25/22 UBS Lifts Brown-Forman Price Target to $33 From $30, Maintains Neutral Rating MT
21/25/21 Barclays Adjusts Price Target on Brown-Forman to $33 From $31, Maintains Overweight Rating MT
20/25/20 JPMorgan Adjusts Price Target on Brown-Forman to $30 From $28, Maintains Underweight Rating MT
12/25/12 Citigroup Adjusts Brown-Forman Price Target to $31 From $28, Maintains Neutral Rating MT
09/25/09 Rothschild Co & Redburn Upgrades Brown-Forman to Neutral From Sell, Adjusts PT to $30 From $40 MT
12/25/12 Truist Cuts Price Target on Brown-Forman to $25 From $35, Keeps Hold Rating MT
More recommendations

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +8.34%
+22.82%
+27.82%
+12.08%
-36.4%
+9.06%
+14.12%
+3.52%
Average +7.67%
Weighted average by Cap. +18.10%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
27.93USD
Average target price
30.26USD
Spread / Average Target
+8.34%
High Price Target
37.50USD
Spread / Highest target
+34.26%
Low Price Target
24.00USD
Spread / Lowest Target
-14.07%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

BNP Paribas Exane
Citigroup
Deutsche Bank Securities
JPMorgan Chase
Evercore ISI
Barclays
Bernstein
UBS
Rothschild & Co Redburn
Truist Securities
Roth Capital Partners
Berenberg Bank
TD Cowen
RBC Capital Markets
Goldman Sachs
Morgan Stanley
Stifel Nicolaus
Roth MKM
Needham & Co.
Consumer Edge
BofA Securities
Wedbush
MKM Partners
Jefferies & Co.
Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
27.93USD
Average target price
30.26USD
Spread / Average Target
+8.34%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. BF.B Stock
  4. Consensus Brown-Forman Corporation